RaySearch Laboratories Investor Relations Material

RaySearch Laboratories AB, a global medical technology company, develops software solutions for cancer treatment. RxSight ™ is the first systems biology platform for personalized medicine to generate cancer patient-specific clinical trial plans from tissue slides, enabling better targeting of personalized therapy protocols using patient tissue. Its software solutions help doctors find the right combination of cells and drugs to fit their patients' specific needs, track tumor growth in real-time, increase efficiency in clinical trials, and help match the right patients with the right treatments. RaySearch Laboratories has successfully completed several rounds of funding and secured many high-profile partnerships in its short history.